ASCP MLT Exam Flashcards

Q: How many questions are on the ASCP MLT exam?

ASCP BOC lists the MLT exam at 100 multiple-choice questions delivered in a 2-hour 30-minute testing window. The exam is administered with computer adaptive testing (CAT) at Pearson VUE test centers, and every scored question has one best answer mapped to the MLT content guideline domains.

Q: What score do I need to pass ASCP MLT?

ASCP BOC reports certification examination scores on a 100-999 scale, with 400 as the minimum passing score. Because the exam uses CAT, the safest answer in one-best-answer scenarios is usually the result interpretation or verification action that protects the patient, not just the arithmetic result.

Q: What topics are tested on the ASCP MLT exam?

The MLT content guideline domains are Blood Banking (15-20%), Urinalysis and Other Body Fluids (5-10%), Chemistry (20-25%), Hematology (20-25%), Immunology (5-10%), Microbiology (15-20%), and Laboratory Operations (5-10%). Chemistry and Hematology are the largest domains and deserve the most study time.

Q: What are the ASCP MLT eligibility routes?

ASCP BOC eligibility is route-specific. The common U.S. MLT Route 1 requires an associate degree or 60 semester hours plus completion of a NAACLS- or ABHES-accredited MLT program within the last 5 years. Route 2 (which required valid CLA(ASCP) certification) was discontinued as of January 1, 2023. Always verify your exact route on the current ASCP BOC MLT page.

Q: How much is the ASCP MLT exam fee in 2026?

The current ASCP BOC MLT application fee is $235 (non-refundable). ASCP BOC permits up to five attempts under one eligibility route; after five unsuccessful attempts, candidates must qualify under an alternate route. The MLT content guideline was revised September 25, 2025.

Q: How should I study for the ASCP MLT exam?

Use a blueprint-weighted plan: prioritize chemistry and hematology first, add repeated blood bank and microbiology practice, and give the 5-10% domains (urinalysis/body fluids, immunology, lab operations) targeted review. Practice calculation-heavy items under time pressure and train result-verification habits (QC rules, delta checks, critical-value reporting).

Question 1

Preanalytical vs Analytical vs Postanalytical Error

Accepted Answer

Quality questions usually ask which phase failed before asking for the next action. Preanalytical = ordering/collection/transport. Analytical = the testing process (QC, calibration, instrument). Postanalytical = result review, reporting, and corrected reports.

Question 2

When NOT to Report a Patient Result

Accepted Answer

An MLT should not release results when QC, calibration, specimen identity, instrument status, or required documentation is unresolved. The safe action is to hold, repeat, dilute, correct, or escalate before release.

Question 3

Westgard QC Rule Recognition

Accepted Answer

A 1_2s control event is a warning. 1_3s, 2_2s, R_4s, 4_1s, and 10x patterns generally require run rejection or investigation under the lab's QC plan. Resolve QC before releasing patient results from that run.

Question 4

Result Verification Checklist

Accepted Answer

Before release, confirm acceptable QC status, valid calibration/method status, acceptable specimen quality, plausible delta check, and correct critical-value handling. A flagged result is investigated, not auto-released.

Question 5

Standard (Universal) Precautions

Accepted Answer

Treat all blood and body fluids as potentially infectious. MLT safety questions emphasize bloodborne pathogen prevention, PPE, safe work practices, specimen/organism transport, SDS use, and emergency response.

Question 6

Anion Gap

Accepted Answer

Calculated from electrolytes to screen for unmeasured anions. An elevated anion gap supports a metabolic acidosis differential. On the exam, tie the calculation to patient-result interpretation, not arithmetic alone.

Question 7

Acid-Base Interpretation Order

Accepted Answer

Solve in sequence: pH first (acidemia vs alkalemia), then pCO2 and HCO3 direction (respiratory vs metabolic), then compensation, and the anion gap if metabolic acidosis is present.

Question 8

Corrected Calcium

Accepted Answer

Total calcium must be interpreted with albumin because much of calcium is protein-bound. Low albumin lowers total calcium without changing the physiologically active ionized fraction; correct or interpret before calling a result abnormal.

Question 9

Hemolysis, Icterus, Lipemia (HIL) Interference

Accepted Answer

These interferents can add analyte, alter absorbance, or create turbidity, making chemistry results look clinically urgent when the real problem is preanalytic. Recognize the specimen issue before reporting.

Question 10

Hepatocellular vs Cholestatic Liver Pattern

Accepted Answer

Hepatocellular injury emphasizes AST/ALT elevation. Cholestasis emphasizes ALP/GGT and direct (conjugated) bilirubin. Use the pattern, not a single analyte, to interpret liver chemistry.

Question 11

Therapeutic Drug Monitoring (TDM) Timing

Accepted Answer

A drug concentration is only interpretable with correct specimen timing, steady-state awareness, and toxicity correlation. A trough drawn at the wrong time can be misleading even if the number is reported.

Question 12

Toxicology Screen vs Confirmation

Accepted Answer

Screening (immunoassay) results are presumptive and must be interpreted with method limits, clinical context, and confirmatory testing policy. A presumptive positive is not a final answer.

Question 13

Specimen Handling Errors That Mimic Disease

Accepted Answer

Delayed serum separation, wrong anticoagulant, IV-line contamination, light exposure, and evaporation can produce results that look like real disease. Suspect preanalytic causes before clinical conclusions.

Question 14

RBC Indices (MCV, MCH, MCHC, RDW)

Accepted Answer

Indices turn the CBC into a classification tool: MCV sizes the cell, MCH estimates hemoglobin per cell, MCHC reflects hemoglobin concentration, and RDW reflects size variation (anisocytosis).

Question 15

Reticulocyte Count

Accepted Answer

Separates underproduction anemia (low/inadequate retic) from a marrow response to blood loss or hemolysis (elevated retic). Use the retic response to classify anemia, not labels alone.

Question 16

Spuriously High MCHC

Accepted Answer

An impossibly high MCHC is a classic clue to a spurious RBC result, often from cold agglutinins, lipemia, or specimen problems. Investigate the specimen and analyzer before reporting.

Question 17

Absolute Neutrophil Count (ANC)

Accepted Answer

ANC = WBC x (% segmented neutrophils + % bands). Interpret leukocytes with absolute counts, not relative percentages alone; ANC is central to neutropenia risk assessment.

Question 18

Auer Rods

Accepted Answer

Cytoplasmic rod-shaped inclusions that support myeloid lineage and a possible acute myeloid process. Their presence should trigger urgent smear review and escalation per procedure.

Question 19

Reactive vs Neoplastic WBC Patterns

Accepted Answer

Toxic neutrophil change and atypical (reactive) lymphocytes are reactive responses and must be separated from blasts or neoplastic patterns that change clinical urgency and escalation.

Question 20

PT/INR vs aPTT

Accepted Answer

PT/INR screens the extrinsic and common pathways. aPTT screens the intrinsic and common pathways. Knowing which pathway each test interrogates drives the coagulation differential.

Question 21

Mixing Study Interpretation

Accepted Answer

If a prolonged clotting time corrects after mixing with normal plasma, suspect a factor deficiency. If it fails to correct, suspect an inhibitor pattern.

Question 22

DIC Laboratory Pattern

Accepted Answer

Disseminated intravascular coagulation shows low platelets, prolonged PT and aPTT, low fibrinogen, and high D-dimer — a consumptive coagulopathy pattern requiring escalation.

Question 23

Clotted EDTA Specimen

Accepted Answer

A clotted EDTA tube can falsely lower platelet and WBC counts and is generally unacceptable for CBC reporting. Recollect rather than report a spurious low count.

Question 24

Citrate Tube Fill for Coagulation

Accepted Answer

Coagulation specimen quality is central: citrate (blue-top) tubes must be properly filled (correct blood-to-anticoagulant ratio), unclotted, and free from anticoagulant carryover, or PT/aPTT can be falsely altered.

Question 25

Forward vs Reverse ABO Typing

Accepted Answer

Forward typing tests patient red cells with anti-A/anti-B reagents. Reverse typing tests patient plasma/serum against known A1 and B cells. A valid ABO interpretation requires forward and reverse agreement.

Question 26

ABO Discrepancy: Safe First Action

Accepted Answer

For an unresolved ABO discrepancy, stop final interpretation, check identity and history, repeat or investigate, and avoid ABO-specific component release until resolved.

Question 27

Extra vs Weak Reverse ABO Reactions

Accepted Answer

Extra reverse reactions often point to cold-reactive antibodies or rouleaux. Weak/missing reverse reactions often point to age, immunosuppression, hypogammaglobulinemia, or recent transfusion.

Question 28

Emergency Unknown-Type Transfusion

Accepted Answer

While testing continues, the classic unknown-type defaults are group O red cells and group AB plasma, prioritizing immediate patient safety over a confirmed type.

Question 29

Antibody Screen vs DAT

Accepted Answer

The antibody screen detects free antibody in patient plasma/serum. The DAT detects red cells already coated in vivo with IgG and/or complement. They answer different questions.

Question 30

Autocontrol/DAT With a Positive Screen

Accepted Answer

A negative autocontrol with a positive screen suggests an alloantibody. A positive autocontrol or positive DAT raises concern for autoantibody, drug effect, transfusion reaction, or in vivo coating.

Question 31

Immediate-Spin / Electronic Crossmatch Eligibility

Accepted Answer

Immediate-spin or a validated electronic crossmatch is appropriate only when the antibody screen is negative and there is no clinically significant antibody history.

Question 32

Blood Component Selection by Defect

Accepted Answer

Match the component to the defect: red cells for oxygen-carrying capacity, platelets for platelet number/function, plasma for multiple coagulation factors, and cryoprecipitate for fibrinogen support.

Question 33

Component Storage Conditions

Accepted Answer

Exam favorites: red cells stored at 1-6 C, platelets at 20-24 C with continuous agitation, and frozen plasma or cryoprecipitate with limited post-thaw life.

Question 34

Suspected Transfusion Reaction: First Action

Accepted Answer

Stop the transfusion, maintain IV access with normal saline, notify the clinical team and blood bank, and begin the clerical and laboratory investigation. Stopping the transfusion comes first.

Question 35

HDFN High-Yield Causes

Accepted Answer

Hemolytic disease of the fetus/newborn is caused by maternal IgG crossing the placenta. Anti-D, anti-c, and anti-K are high-yield severe causes; ABO HDFN is usually milder.

Question 36

Rh Immune Globulin (RhIG) Purpose

Accepted Answer

RhIG prevents anti-D alloimmunization in an unsensitized Rh-negative pregnant patient when fetal/neonatal D-positive exposure is possible.

Question 37

Sterile vs Nonsterile Site Culture Interpretation

Accepted Answer

Sterile-site growth is interpreted differently from nonsterile sites, where contamination, normal flora, quantity, and inflammation change the meaning of growth.

Question 38

Specimen Acceptability Before Identification

Accepted Answer

Acceptability starts with patient ID, source, collection method, transport condition, and rejection criteria before any organism conclusion. Reject poor specimens (e.g., saliva-contaminated sputum).

Question 39

Identification Starting Point

Accepted Answer

The fastest ID path starts with Gram reaction, morphology, arrangement, colony features, and specimen source — then a small set of biochemical tests.

Question 40

High-Yield Bench Tests

Accepted Answer

Catalase, coagulase, oxidase, indole, PYR, CAMP, bile esculin, 6.5% NaCl tolerance, urease, H2S, and optochin are core MLT-level differentiation tests.

Question 41

Selective/Differential Media Are Not Interchangeable

Accepted Answer

MacConkey, chocolate, Thayer-Martin, BCYE, Lowenstein-Jensen, Sabouraud, TCBS, and mannitol salt each answer a different question. Choose media by what you need to recover or differentiate.

Question 42

Acid-Fast Stain Basis

Accepted Answer

Acid-fast staining works because of the mycolic-acid-rich cell wall of mycobacteria. Mycobacterial workups require special processing, media, long incubation, and biosafety awareness.

Question 43

Disk Diffusion (Kirby-Bauer) Setup

Accepted Answer

Routine disk diffusion uses Mueller-Hinton agar and a 0.5 McFarland inoculum for many bacteria. Zones or MICs must be interpreted with current laboratory-approved breakpoints.

Question 44

Out-of-Range AST Quality Control

Accepted Answer

Out-of-range antimicrobial susceptibility QC is a stop-and-troubleshoot event. Affected patient susceptibility results should not be reported until QC issues are resolved per policy.

Question 45

Urine Strip vs Microscopy Correlation

Accepted Answer

Reagent-strip results must be correlated with microscopy, specific gravity, pH, color, clarity, and specimen freshness. Discrepancies require investigation before reporting.

Question 46

Urinary Casts Localize to the Kidney

Accepted Answer

RBC casts suggest glomerular bleeding, WBC casts suggest renal inflammation, and broad waxy casts suggest chronic tubular stasis. Casts point findings to the kidney itself.

Question 47

CSF Red Flags

Accepted Answer

Rapid cell deterioration, neutrophilic pleocytosis with high protein and low glucose, organisms on Gram stain, and xanthochromia are policy-driven escalation triggers. CSF is prioritized over most other specimens.

Question 48

Serous Fluid: Light's Criteria Concept

Accepted Answer

Serous (pleural/peritoneal) fluids are decision-pattern topics: Light's criteria separate transudate from exudate, and infection or malignant-cell clues matter more than isolated memorization.

Question 49

Antigen-Antibody Method Families

Accepted Answer

Most MLT immunology methods rest on antigen-antibody binding: agglutination, precipitation, labeled immunoassays, immunofluorescence, lateral flow, and reflex molecular testing.

Question 50

Serology vs Molecular Testing

Accepted Answer

Nucleic acid (molecular) tests detect pathogen genetic material; serology detects host antibody or pathogen antigen. Infectious serology often follows screen-confirm-resolve logic (e.g., HIV, hepatitis B patterns, syphilis treponemal/nontreponemal).

Free ASCP MLT Exam Flashcards

Filter by Topic

Jump to Card

About These ASCP MLT Flashcards

Topics Covered

Frequently Asked Questions

ASCP Medical Lab Technician (MLT)

Explore More ASCP Certifications

ASCP Medical Laboratory Scientist (MLS)

ASCP Phlebotomy Technician (PBT)

ASCP Blood Banking Technologist

ASCP Hematology Technologist

ASCP Molecular Biology Technologist

ASCP CG Scientist in Cytogenetics

More From This Family